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Introduction
The repair of cartilage defects in humans can be a difficult
endeavor, and multiple options exist for the surgeon to
approach this topic. The surgeon may choose to influence
the defect with microfracture or abrasion techniques to
stimulate a fibrocartilage patch in which to fill the defect.
There are also options available that allow for the filling of
the defect with chondrocytes of variable sources, both of
autograft and allograft origin. The goal with all of these
procedures is to replace cartilage defects with cartilage
or cartilage-like material that is as close to normal
hyaline cartilage as possible. An ideal choice for cartilage
restoration and repair would be something that is readily
available, easy to place in a defect, and minimal morbidity
to the patient.
Multiple studies exist expounding on the potential uses
of human amniotic cells in various platforms for tissue
repair. It has been proven that amniotic cells are pleripotent
in nature and can be influenced to produce various cell lines
including chondrocytes.1 Further, it has been shown in the
lab that demineralized bone can influence pluripotent cells
to produce chondrocyte and osteoblast type cells.1 The
potential for this knowledge to be used to repair cartilage
defects has not been explored to the knowledge of the
authors up to this point.
This study evaluates the use of human amniotic membrane
mixed with demineralized bone to fill cartilage defects in a
sheep model. It is hypothesized that this membrane would
be able to fill these defects with chondrocyte-like cells, and
that the defects would be filled with hyaline cartilage.

Method
Six adult sheep (less than three years old) where chosen for
the study. Each of the sheep was evaluated by a licensed
veterinarian and was determined to be healthy and
without any limb deformity. Each sheep was anesthetized
by a licensed veterinarian and one hind-quarter knee of
each was sterilized and surgically exposed. Two cartilage
defects were created using curettes, one on the weightbearing surface of the femoral condyle and one in the
trochlear grove (Figure 1). The defects did not violate the
subchondral bone. Three sheep were used as control sheep
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and the defects were left unfilled. Three sheep were chosen
to receive human amniotic membrane.

Figure 1: Cartilage Defect

The membrane was procured from a placenta and cut
to fit the defect. The portion of the placenta utilized was
from the outer membrane of the placenta that has been to
shown to have pluripotent cells.2 Care was taken to place
the shiny epithelial layer away from the bone defect because
this layer does not have pluripotent cells. The membrane
was folded so that the pluripotent cellular layer faced the
defect and the joint. Between the layers a small amount
of sterilized demineralized human bone was placed in a
sandwich-like manner (Figure 2). The membranes were
fixed to the defects on the femoral chondyles using micro
bone anchors and fibrin glue. The membrane was fixed to
the trochlear defects using fibrin glue alone. The wounds
were closed and the sheep were allowed to weight bear as
tolerated immediately after surgery.
The wounds were evaluated at regular intervals to
evaluate for infection and swelling. The sheep were clinically
evaluated and a lameness rating was taken at set intervals.
At six months post-procedure, the sheep were sacrificed
and the distal femurs were harvested. Histological samples
were taken of each of the operative sites, both those treated
with amniotic membrane and without membrane. Normal
cartilage samples were taken from each of the sheep for
comparison. The histological samples were taken using
mosaicplasty coring instruments to minimize cartilage
damage.
The samples from each sheep were evaluated grossly
and on a cellular level. Of the sheep that had amniotic
membranes placed in their defects, 50% retained the
membrane grossly. All of the retained samples were in

the trochlear groove defects. None of the samples on the
femoral condyles retained the amniotic membrane. For
this reason, analysis of the samples was only performed on
those samples that retained the amniotic membrane.
The samples were stained with both H&E and Trichrome
staining. Each of the samples (normal, control, and treated)
was evaluated using a straight-forward scoring system that
is a validated cartilage evaluation method. This evaluation
method rates the sample on two levels. First the sample is
rated 0-3 on overall appearance (0 = no cartilage present, 3
= mostly normal appearing cartilage) which was referred

samples taken from the sheep. There was a strong statistical
correlation showing very little difference between the test
samples and the normal cartilage. The defects that retained
their membranes had evidence of diffuse chondrocyte-like
cell proliferation and showed a stromal matrix similar to
hyaline cartilage.

Conclusion
Human amniotic membrane is a potential source of
plueripotent cells that can be influenced to produce cartilage
in defects in sheep model. The implications for application
in a human model are promising and warrant further study.

References
1. Zhou S, et al. Demineralized bone promotes chondrocyte
or osteoblast differentiation of human marrow stromal cells
cultured in collagen sponges. Cell Tissue Bank. 2005;6(1):3344.
2. Marongiu F, et al. Isolation of Amniotic Mesenchymal
Stem Cells. Current Protocols in Stem Cell Biology.
2010;1E.5.1-1E.5.11.
3. O’Driscoll SW, et al. Validation of a Simple HistologicalHistochemical Cartilage Scoring System. Tissue Engineering.
2001;7(3).
Evaluation

Figure 2: Placental Preparation

to as “simple score”. Next, each sample was given a % value
of cartilage-like tissue, these values were referred to as “%
score”. All samples were evaluated by both of the authors
who were blinded to the results of the other observer.

Results
The lameness of each of the sheep was evaluated by the
veterinarian at set intervals. All but one of the sheep
(control) regained full range of motion (ROM) in the limb.
All but the sheep that lost some ROM in the limb was rated
at a lameness level of 0-1 at final evaluation. Table 1 details
the lameness evaluation of each of the sheep.
Of the control sheep, none of the defects filled in with
hyaline cartilage or fibrocartilage. In the sheep in which
membranes were placed, 50% of the defects appeared
to retain the membrane, which is consistent with other
similar animal models. Samples of the membrane defects
were examined histologically based on a simple, validated
scoring system. These samples were compared to normal
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